MedTrace Logo

Phase IV-Cervical Dystonia-INTEREST IN CD2

NCT01753349 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1050

Last updated 2020-11-05

No results posted yet for this study

Summary

The purpose of the study is to document long-term response in real-life practice after injection cycles with BoNT-A in subjects suffering from idiopathic cervical dystonia (Long-term clinical and pharmaco-economic data).

Conditions

  • Cervical Dystonia

Interventions

BIOLOGICAL

Botulinum toxin type A

Investigators were free to prescribe any BoNT A preparation, including Dysport, Botox and Xeomin.

Sponsors & Collaborators

Principal Investigators

  • Ipsen Medical Director · Ipsen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2017-09-30
Completion
2017-09-25

Countries

  • United States
  • Algeria
  • Australia
  • Austria
  • Belgium
  • Brazil
  • China
  • Czechia
  • Estonia
  • France
  • Germany
  • Hungary
  • Israel
  • Italy
  • Jordan
  • Latvia
  • Lebanon
  • Malaysia
  • Mexico
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russia
  • Serbia
  • Singapore
  • Slovenia
  • South Korea
  • Sweden
  • Taiwan
  • Thailand
  • Turkey (Türkiye)
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01753349 on ClinicalTrials.gov